InDex Pharmaceuticals: CONDUCT progressing according to plan & new insights into cobitolimod’s MoA
Research Update
2018-03-14
07:30
CONDUCT is progressing according to plan and results could be presented in Q4-2018. We see a good investment case in INDEX for 2018. Note: This is a translation of the original report in Swedish, published today.
MS
Mathias Spinnars
Disclosures and disclaimers